AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $365,000 | -71.3% | 24,100 | -85.8% | 0.00% | 0.0% |
| Q2 2022 | $1,271,000 | -9.4% | 169,375 | +9.8% | 0.00% | 0.0% |
| Q1 2022 | $1,403,000 | +83.6% | 154,205 | +41.7% | 0.00% | 0.0% |
| Q4 2021 | $764,000 | -50.8% | 108,825 | -20.1% | 0.00% | 0.0% |
| Q3 2021 | $1,553,000 | -28.8% | 136,225 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $2,181,000 | -20.0% | 136,225 | -10.7% | 0.00% | -33.3% |
| Q1 2021 | $2,727,000 | +32.3% | 152,580 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $2,061,000 | +14.8% | 152,580 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,795,000 | -14.2% | 152,580 | +7.7% | 0.00% | 0.0% |
| Q2 2020 | $2,091,000 | +120.6% | 141,630 | +101.6% | 0.00% | +100.0% |
| Q1 2020 | $948,000 | -13.1% | 70,255 | +55.7% | 0.00% | 0.0% |
| Q4 2019 | $1,091,000 | +27.9% | 45,121 | +3.4% | 0.00% | 0.0% |
| Q3 2019 | $853,000 | -35.5% | 43,648 | -2.4% | 0.00% | 0.0% |
| Q2 2019 | $1,322,000 | -54.7% | 44,738 | -27.2% | 0.00% | -66.7% |
| Q1 2019 | $2,921,000 | +86.6% | 61,485 | +41.8% | 0.00% | +50.0% |
| Q4 2018 | $1,565,000 | – | 43,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|